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(57) ABSTRACT 
The present invention is a process for treating a feedstock 
comprising holocellulose. The process comprises mixing the 
feedstock with a solution comprising cellulose binding 
domains to form a mixture. The mixture is then subjected to 
conditions sufficient to reduce the crystallinity of holocellu-
lose. Subsequent enzymatic hydrolysis may show an 
improved rate and/or fermentable sugar yield as compared to 
processes which do not employ the process. 
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METHODS OF TREATING A BIOMASS FOR 
ENZYMATIC HYDROLYSIS 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
For purposes of United States patent practice, the contents 
of U.S. Provisional Application No. 61/266,618 filed Dec. 4, 
2009 is herein incorporated by reference in its entirety to the 
extent that it is not inconsistent. 
FIELD OF THE INVENTION 
The present invention pertains to improved methods for 
treating a feedstock comprising holocellulose using, for 
example, a solution comprising cellulose binding domains 
prior to enzymatic hydrolysis. 
BACKGROUND AND SUMMARY OF THE 
INVENTION 
2 
ment with CBD, treatment with buffer, no treatment with 
simultaneous addition of CBD, and no treatment (dry 
sample). 
FIG. 13 shows the SDS-PAGE before and after papain 
5 cleavage of cellulases. 
FIG. 14 shows the XRD spectra for Avicel samples treated 
with CBDcenA (cellulose-binding domain from purified 
Cel7 A), CDcenA (catalytic domain) or buffer. 
FIG. 15a shows the hydrolysis profile of Avicel after pre-
10 treatment with mixture ofCBDs for 15 hat 42° C. 
FIG. 15b shows the hydrolysis profile of fibrous cellulose 
(FC) after pretreatment with mixture ofCBDs for 15 hat 42° 
C. 
FIG. 16 shows the hydrolysis profile of Avicel after pre-
15 treatment with CBDcenA for 15 hat 42° C. 
FIG.17 shows effect of various CBD concentrations in the 
pretreatment step (15 hat 42° C.) on hydrolysis rate. 
FIG. 18 shows the effect of stir bar during pretreatment of 
cellulose with CBDs on hydrolysis rates. 
20 FIG.19 shows amino acid sequences of various CBDs that 
may be useful in the present inventions. 
The enzymatic hydrolysis of cellulose to glucose has 
gained increased interest over the last ten years, and growing 
demand for economically sustainable biofuels points to an 
urgent need for reducing costs in their production. Cellulose, 25 
a polysaccharide made by many plants, is one of the most 
abundant organic compounds on Earth and therefore repre-
sents a potential goldmine for the biofuel industry. However, 
current enzymatic degradation of cellulose faces major issues 
that prevent its wide utilization to produce, for example, 30 
economically competitive biofuel. Such issues may include, 
DETAILED DESCRIPTION OF THE INVENTION 
In general terms the instant invention pertains in one 
embodiment to a process for treating a feedstock comprising 
holocellulose. The process comprises mixing the feedstock 
with a solution comprising cellulose binding domains to form 
a mixture. The mixture is then subjected to conditions suffi-
cient to reduce the crystallinity ofholocellulose. Subsequent 
enzymatic hydrolysis may show an improved rate and/or 
for example, low reaction and/or conversion rates. 
Advantageously, the inventors have discovered a process 
and composition which accomplishes the aforementioned 
goals and more. In general terms the instant invention pertains 35 
in one embodiment to a process for treating a feedstock com-
prising holocellulose. The process comprises mixing the 
feedstock with a solution comprising cellulose binding 
domains to form a mixture. The mixture is then subjected to 
conditions sufficient to reduce the crystallinity ofholocellu- 40 
lose. Subsequent enzymatic hydrolysis may show an 
improved rate and/or fermentable sugar yield as compared to 
processes which do not employ the CBD treatment process. 
fermentable sugar yield as compared to processes which do 
not employ the CBD treatment process prior to a subsequent 
hydrolysis. Advantageously, the fermentable sugar in the 
hydrolyzed composition and/or the hydrolysis rate may be at 
least about 10%, or at least about 15%, or at least about 20%, 
more than a comparable process which does not employ 
cellulose binding domains. Following hydrolysis to produce 
one or more fermentable sugars such as glucose, processes 
such as fermentation may be employed to produce, for 
example, bioethanol. 
Feedstock Comprising Holocellulose 
The nature of the feedstock employed in the processes and 
compositions herein is not particularly critical so long as the 
BRIEF DESCRIPTION OF THE FIGURES 
FIG. 1 illustrates an SDS-PAGE gel of purified cel7 A from 
Trichoderma reesei and cel7 A catalytic domain after papain 
cleavage. 
FIG. 2 illustrates the enzymatic hydrolysis of Avicel after 
CBD treatment. 
FIG. 3 illustrates the effect of various CBD incubation 
times. 
FIG. 4 shows the effect of buffer incubation on hydrolysis 
rate compared to CBD incubation (13 h). 
FIG. 5 shows the effect of buffer incubation time on 
hydrolysis rates. 
FIG. 6 shows the results of a CBD concentration optimi-
zation experiment. 
45 feedstock comprises holocellulose. As used herein, "holocel-
lulose" means at least a portion of the water-insoluble carbo-
hydrate portion of a biomass, i.e., the portion of the biomass 
that is not lignin, extractives, or ash, but rather, includes 
substances such as polysaccharides. The precise, composi-
50 ti on of holocellulose may vary depending upon the specific 
feedstock employed. However, holocellulose useful herein 
typically comprises various amounts of celluloses such as 
alpha-cellulose and hemicellulose and may contain various 
pentosan or hexosan polymers. Thus, virtually any lignocel-
55 lulosic biomass that comprises cellulose may be employed as 
the feedstock in the processes and compositions of the instant 
invention. The invention may be advantageously employed 
on compositions comprising cellulose in which the crystal-
linity of the cellulose is in need of reduction. 
FIG. 7 shows hydrolysis for various CBD treatment times. 60 
FIG. 8 shows the effect of various concentrations ofCDB. 
FIG. 9 shows the effect of sequential addition and CBD 
In one embodiment a particularly preferable feedstock is a 
plant biomass. Biomass comes in many different types, which 
may be grouped into a few main categories: wood or forestry 
residues, including sawmill and paper mill discards, munici-
pal paper waste, algae, agricultural residues, including corn 
removal. 
FIG. 10 shows the effect of a 45° C. treatment. 
FIG. 11 shows the effect of a 50° C. treatment. 
FIG. 12 shows the amount of reducing ends produced from 
switchgrass using cellulases and ~-glucosidase after treat-
65 stover (stalks and straw), and sugarcane bagasse, and dedi-
cated energy crops, which are mostly composed of fast grow-
ing tall, woody grasses such as, for example, switchgrass. 
US 8,506,717 B2 
3 
Any of the aforementioned may find use in the instant inven-
tion. A particularly preferable biomass comprises one with 
high cellulose content. 
Depending upon the nature of the feedstock it may be 
desirable to reduce at least a portion of it in size in order to 
expose additional surface area for treatment. Such reduction 
may be done in any convenient manner such as by grinding, 
cutting, chopping, etc. The desired size of the feedstock varies 
depending upon the type of ingredients and other specifics of 
the instant inventions. Typically, smaller size feedstocks may 10 
react quicker but cost more to produce. Generally, it is advan-
tageous if the feedstock is reduced prior to CBD treatment 
and/or prior to hydrolysis. 
Similarly, it is often advantageous, or may even be neces-
sary, in some situations to first purify at least a portion of the 15 
feedstock. By purify is meant to partially clean in order to 
remove at least some contaminants that may negatively effect 
downstream processes. This purification may assist in reduc-
ing or eliminating any undesired reactions in the following 
steps. The type of purification will depend upon the source of 20 
the feedstock, as well as, the amount and nature of the impu-
rities and the following steps to which it will be subjected. 
Often, simple washing of the lignocellulosic feedstock is 
sufficient. Such purification, if done, may be accomplished 
prior to, in conjunction with, or subsequent to any size reduc- 25 
tion. Additionally, if desired or advantageous, at least a por-
tion or all of the feedstock that does not comprise holocellu-
lose may be separated. However, this is urmecessary for many 
processes and conditions to which the composition will likely 
be subjected. 30 
Cellulose Binding Domain (CBD) 
The cellulose binding domains employed herein are typi-
cally derived from cellulases. Cellulases are glycosyl hydro-
lases of varying structure which catalyze the hydrolysis of 
1,4-~-D-glycosidic bonds. Most cellulases comprise three 35 
domains: (1) a catalytic domain which primarily serves as the 
locus of hydrolysis, (2) a cellulose-binding domain that often 
assists in anchoring the whole enzyme onto the cellulose 
surface and/or in orienting the cellulose fiber towards the 
tunnel containing the active site, and (3) a glycosylated flex- 40 
ible linker connecting the two other domains and often pro-
viding sufficient spatial separation between them. The linker 
may also assist in allowing processive motion and/or assisting 
in energy storage. 
As used herein the term "cellulose binding domain" or 45 
"CBD" is a portion of cellulase that includes a substantial 
portion of the aforementioned (2) but lacks a substantial 
portion, the majority, or all of (1). Such cellulose binding 
domains in some embodiments include all or at least a portion 
of the linker (3) while in other embodiments the linker (3) is 50 
modified or absent from the cellulose binding domain 
employed. Thus, useful CBD for use herein may often be 
obtained from cellulase by cleaving CBD and, if desired, 
linker from the cellulase in a convenient method such as, for 
example, proteolytic cleavage. Depending upon the cleaving 55 
method, the CBD may then be recovered in a convenient 
manner such as, for example, filtration. In some embodi-
ments, the ratio of cellulose binding domains to catalytic 
domain is greater than 1 : 1, or greater than 2: 1, or greater than 
3: 1, or greater than 5: 1, or greater than 10: 1. 60 
The nature and type of cellulose binding domain employed 
is not particularly critical so long as they function in some 
manner to reduce the crystallinity of cellulose and/or facili-
tate any further processing such as hydrolysis. Suitable CBSs 
may be derived from a suitable enzyme produced by a species 65 
like, for example, a Trichoderma species such as T. reesei, T. 
viride, as well as, for example, Phanerochaete chrysaspo-
4 
rium, Humicola insolens, Coprinopsis cinerea, Acremonium 
cellulolyticus, Hypocrea jecorina, Penicillium occitanis, 
Irpex lacteus, Penicillium echinulatum, Lentinula edodes, 
Penicillium decumbens. 
In one embodiment the cellulose binding domains are 
derived from cellobiohydrolase ( cel7 A) such as produced by, 
for example, a Trichoderma species like Trichoderma reesei. 
In another embodiment the cellulose binding domains are 
derived from cellobiohydrolase II (cel6A). In other embodi-
ment the cellulose binding domains are derived, for example, 
from an enzyme in Table 5 below. In another embodiment the 
cellulose binding domains employed may be a mixture of two 
or more of the aforementioned. The CBD 
Cellulose-binding domains (CBDs) of cellulases from Tri-
choderma reesei (belonging to family I CBD) form a wedge-
like fold, where a flat face provides key (aromatic) residues 
strongly interacting with crystalline cellulose. Such methods 
as those described in the below examples may be employed. 
In addition, with the benefit of the instant disclosure, one of 
skill may employ routine testing of other substances to iden-
tify useful materials. Alternatively or additionally, protein 
engineering may be conducted on CBD. Mutations of certain 
residues on CBD (such as those involved in binding or inter-
acting with cellulose and/or any that may effect a faster 
hydrolysis rate) may then be exploited to develop CBD tai-
lored to, for example, specific feedstocks and/or process con-
ditions. 
Mixing the Feedstock with a Solution Comprising Cellulose 
Binding Domains 
The solution comprising cellulose binding domains may be 
made and mixed with the feedstock in any convenient man-
ner. The concentration of the solution comprising cellulose 
binding domains varies depending upon the particular feed-
stock, other ingredients of the solution such as buffer, and the 
conditions to be employed. Generally, it should have a con-
centration at least sufficient to reduce the crystallinity of the 
cellulose at the treatment conditions but not so high that it 
interferes with any subsequent desired processing steps such 
as hydrolysis. Generally, a concentration of at least about 5, or 
at least about 10, or at least about 15 up to at most about 100, 
or at most about 75, or at most about 55, or at most about 45, 
or at most about 35 µg/ml may be effective. A suitable buffer 
may also be employed in the solution if desired. It may be 
advantageous to employ a buffer which acts synergistically 
with the CBD to even further facilitate reducing the crystal-
linity of the cellulose. Suitable buffers often include salts or 
esters of lower alkyl acids such as acetic acid and typically 
have a pH of from about 4.5 to about 5.5. In one embodiment, 
the solution comprises a sodium acetate buffer at a concen-
tration of from about 25 to about 75 mM. 
CBD Treatment Conditions 
Once a mixture comprising one or more feedstocks with a 
solution comprising cellulose binding domains is made, then 
the mixture is subjected to conditions sufficient to reduce the 
crystallinity of holocellulose and/or facilitate a subsequent 
hydrolysis. These conditions may vary widely depending 
upon the nature and type of feedstock and the type and 
amount of ingredients in the solution comprising cellulose 
binding domains. 
Typically, the mixture is subjected to an increased tempera-
ture for a time sufficient to reduce the crystallinity of holo-
cellulose. Such temperatures vary but may be at least about 
30° C., or at least about 35° C. up to at most about 60° C., or 
at most about 50° C., or at most about 45° C. Generally, the 
higher the temperature employed, the shorter the time that the 
mixture must be heated and vice versa. At the previously 
described temperatures, suitable times to which to subject the 
US 8,506,717 B2 
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mixture to increased temperature at least about 8 hours, or at 
least about 10 hours, or at least about 12 hours, or at least 
about 14 hours, up to at most about 48 hours, or at most about 
24 hours, or at most about 16 hours. Using the present dis-
closure, one of skill in the art may use routine experimenta-
tion to determine proper times and temperatures for a particu-
lar feedstock and composition. 
Without wishing to be limited to any particular theory, it is 
believed that the cellulose binding domains and similar pro-
teins reduces the degree of crystallinity, and therefore renders 10 
the cellulose less recalcitrant to enzymatic attack. The afore-
mentioned processes of the instant invention may be used 
alone or in conjunction with other techniques to decrease the 
crystallinity to a desired level. Such techniques may be used 
before, during, or after the processes of the instant invention 15 
and include, for example, (thermo )chemical and/or mechani-
cal techniques (e.g. treatment with phosphoric acid, ionic 
liquids or organic solvents, APEX, and ball mill grinding). In 
some instances purification may be beneficial before the 
hydrolysis step (e.g. with ionic liquids). In some instances it 20 
may be advantageous to subject the mixture to sufficient 
stirring such that substantially all solids are suspended. For 
example, in some instances the mixture is subjected to stir-
ring, preferably vigorous, in a vial with a stir bar. In some 
embodiments the stir bar has a diameter of at least about 45%, 25 
preferably at least about 50%, preferably at least about 55%, 
of the inner vial diameter. 
6 
(3) incubating, i.e., treating, cellulose (Avicel) with a solution 
comprising CBD; and 
(4) adding cellulase cocktail (from Trichoderma reesei) and 
monitoring hydrolysis rate (via glucose content). 
General Procedure for CBD Production 
Following the procedure on CBD cleavage from the core 
protein as used in, for example, P. Tomme et al., Eur. J. 
Biochem., 1988, 170, 575-581, papain was employed to per-
form the proteolytic digestion under the following condi-
tions: 
1. Activation of papain in 50 mM NH4 0Ac buffer pH 6.0 at 
30° C. for 30 min; 
2. Addition of papain to cel7 A solution (in 50 mM NaOAc 
buffer, pH 5.0) at 30° C., ratio papain/cel7 A 1 :5 (w/w, v/v); 
3. Stirring for 2 hat 30° C.; and 
4. Filtration of the reaction mixture through 30 kDa mem-
brane ( 4000 rpm for 15 min) to collect the cellulose binding 
domain (attached to the linker) in the filtrate. 
The cleavage reaction was found to be complete after 2 h, 
and no remaining cel7A (-64 kDa) could be detected by 
SDS-PAGE as shown in FIG. 1. The reaction led to the for-
mation of a single strong band, with a molecular weight of 50 
kDa. The papain successfully cleaved offCBD+linker from 
the core protein (CD); however, this small protein fragment 
(-14 kDa) was not detected by SDS-PAGE (the sequence 
shows very few residues that can react with commonly used 
Coomassie dye-staining). However, CBD was detected via 
micro BCA protein assay (bicinchoninic acid) in the filtrate In another embodiment, the instant invention pertains to 
the use of a solution or composition comprising cellulose 
binding domains in a pre-treatment step in, for example, a 
cellulose hydrolysis process. The solution or composition 
comprising cellulose binding domains is as described above 
and below. Similarly, the pre-treatment step is as described, 
i.e., first mixing a hollocellulosic feedstock with the solution 
30 
(<30 kDa) (Table 1, 100% recovery). 
or composition comprising cellulose binding domains to 35 
form a mixture and then subjecting the mixture to conditions 
sufficient to reduce the crystallinity of holocellulose. The 
specific ingredients, conditions, etc. may be as described 
elsewhere herein. 
40 
EXAMPLES 1-8 
General Procedure for CBD Treatment of Avicel 
TABLE 1 
Cel7A fragments recovery after papain cleavage 
Protein fragments 
Cel7A (+papain) 
before reaction 
CD ( +papain) concentrate 
after filtration through membrane > 30 kDa 
CBD filtrate 
after filtration through membrane <30 kDa 
Expected CBD 
(-10-14 kDa from 64 kDa) 
Example IA 
Total mass 
(mg) 
4.6mg 
3.8mg 
0.6mg 
0.6-0.9 mg 
Avicel Treatment with a Solution Comprising 
Cellulose Binding Domain (CBD) and Measurement 
of Crystallinity Via X-Ray Diffraction 
Cellobiohydrolase I ( cel7 A) is a component of a cellulase 
mixture which is an exoglucanase which attacks cellulose 45 
chains from the reducing-end side. The following inventive 
examples employ the cellulose-binding domains (CBD) from 
this enzyme, and more specifically cel7 A from Trichoderma 
reesei, a commonly used organism in the production of, for 
example, bioethanol. The effect of CBD on cellulose was 50 
investigated, i.e. the consequence of cellulose incubation, i.e., 
treatment, in a solution comprising CBD on the degree of 
crystallinity, and subsequently on the enzymatic hydrolysis 
rate of the reaction performed with the CED-treated cellu-
lose. 
While not wishing to be bound to any particular theory it is 
believed that the activity of CBD relates to non-hydrolytic 
disruption of cellulose and a weakening and splitting of the 
55 hydrogen-bonding network in cellulose. The following inves-
tigation determined whether that activity was strong enough 
to reduce cellulose crystallinity. 
Cel7 A is constituted of three domains: a cellulose-binding 
domain (CBD), a catalytic domain (CD) and a highly glyco-
sylated linker that joins the CBD to the CD. The examples 
involve: 
(1) producing CBD from cel7 A, via proteolytic cleavage of 60 
that fragment (plus linker) from the CD using papain (a 
cysteine protease); 
(2) recovering CBD via filtration through a 30 kDa membrane 
(CBD+linker-61 residues; theoretical size-6 kDa; esti-
mated size from experiments-14 kDa due to 0-glycosyla- 65 
tion of the linker; estimated size of CD-50 kDa due to 
N-glycosylation); 
Avicel was treated with CBD solution (obtained as 
described above), and the degree of crystallinity of the recov-
ered cellulose was subsequently determined via X-ray dif-
fraction using our recently developed analytical method 
described in, for example, Bansal et al., Multivariate statisti-
cal analysis of X-ray data from cellulose: A new method to 
determine degree of crystallinity and predict hydrolysis rates. 
Bioresource Technol., 101, 4461-4471. 
The cellulose treatment step was performed as follows: 
Avicel (20 mg/ml) in CBD solution (50 mM NaOAc buffer, 
US 8,506,717 B2 
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pH 5) was stirred at 37° C. for 2 days. The mixture was 
centrifuged at 4000 rpm for 15 min and recovered cellulose 
was freeze-dried. The powder was analyzed by the X-ray 
diffraction method referred to above. 
Avicel is a microcrystalline cellulose with an average 
degree of crystallinity of about 60%. Upon treatment with the 
CBD solution, a significant decrease in Avicel crystallinity 
was observed as shown in Table 2 below. The highest decrease 
8 
time that led to the 13% decrease in crystallinity (see above) 
was varied from 8 h to 24 hand the enzymatic hydrolysis rates 
were examined. One single CBD solution was used through-
out these experiments, so that they were performed at con-
stant CBD concentration (-42 µg/ml). Positive effects of 
CBD were obtained between 8 hand 13 h ofincubation at 37° 
C. Beyond 13 h, no further increase in rates was observed as 
shown in FIG. 3. Depending on the incubation time, a maxi-
of 13% was obtained with sample 4 which corresponded to 
4.7 ml of filtrate obtained from the cleavage of3.3 mg cel7A 
10 in 7 ml buffer. 
mum of 20-25 percentage points difference was observed in 
glucose content (corresponding to 50-60% increase in rate 
between the 8 h and > 13 h CBD treatment times). 
TABLE2 
Degree of crystallinity (Cr!) of Avicel after incubation (2 days) 
witb cellulose-binding domain (CBD) or catalytic domain (CD) 
No treatment 
prior to 
Cr!(%)* CBD CD hydrolysis 
57.2 59.6 60% 
2 57.4 60.3 
56 61 
4 52 62 
*samples 1-4referto different experiments. 1 and 2 were run at low CBD concentrations, 3-4 
at higher CBD concentration 
Example 1B 
Enzymatic Hydrolysis of CBD Treated Samples of 
Example IA 
However, incubation in buffer was found to also have a 
positive effect on hydrolysis rate. Despite lower conversion 
compared to incubation with CBD solution, conversion on 
sample incubated in buffer for 13 h was higher than after 1 h 
15 incubation in buffer as shown in FIG. 4. When conversion on 
CBD treated sample was up to two-fold higher than that on 
buffer-treated sample for 1 h (after 1 h hydrolysis), the dif-
ference was less significant between the CBD treated sample 
and the buffer treated sample for 13 h (1.3-1.4 fold higher). 
20 The effect of buffer on hydrolysis rate was shown to be 
time-dependent, however, no major difference was observed 
between 13 hand 48 h of incubation in buffer, although an 
incubation for 24 h led to the highest rates as shown in FIG. 5. 
Interestingly, water incubation (18 h) showed a positive effect 
25 on rate (higher conversion than with 1 h incubation in buffer), 
however, less pronounced than with similar incubation time 
in buffer.A pH shift is suspected, as water had a pH of5.5, 0.5 
units higherthan the pH of the buffer (50 mMNaOAc pH 5). 
Crystallinity measurements were then conducted on cellu-
30 lose samples preincubated in buffer only and water only, 
respectively. No significant change from the untreatedAvicel 
was observed after 24 h incubation at 37° C. (apart from a 
slight increase in crystallinity up to 63%, which should not 
The cellulose samples (3 and 4, Table 2) that presented a 
significant lower crystallinity value compared to untreated 
Avicel were submitted to enzymatic hydrolysis using the 
cellulase cocktail from Trichoderma reesei (supplemented 
with ~-glucosidase to prevent product inhibition). A signifi- 35 
cant increase inrate was observed forthe samples treated with 
CBD solution prior to hydrolysis, with an overall rate 2-fold 
higher than that of untreated Avicel over the course of the 
reaction as shown in FIG. 2. Thus, the decrease in crystallinity 
observed after treating Avicel with CBD solution correlated 
well with a decreased recalcitrance to enzymatic attack, and 
therefore a faster conversion to glucose. 
relate to an increase in rate in many cases). 
Next, the CBD concentration was varied, starting from a 
reference volume (Vr added to the reaction mixture, corre-
sponding to a final CBD concentration of 24 µg/ml). Higher 
concentrations (up to 4 Yr) and lower concentrations (down to 
0.14 Yr) were examined. Overall, the effect ofCBD was less 
40 pronounced than in the previous examples as shown in FIG. 6. 
The highest rates were obtained with 0.28 Yr, whereas both 
lower and higher concentrations (0.14 Yr and 4 Yr resp.) led 
to lower conversion. At higher CBD conversion, where cel-
lulases added to perform hydrolysis have less binding spots 
General Procedure to Measure Effect ofYarious CBD Treat-
ment Conditions 
The following shows the effect of various CBD treatment 
conditions on hydrolysis rates. As crystallinity was shown to 
decrease, no additional crystallinity measurement was con-
ducted and therefore cellulases were directly added to the 
reaction mixture after CBD treatment time was over, i.e. the 
samples were not freeze-dried before investigation of 
hydrolysis rates, nor was the buffer exchanged or the solution 
diluted. The sequential CBD treatment and hydrolysis pro-
cess was performed as followed: 
1. Incubating Avicel with CBD solution over various time 
lengths at 37° C.; 
2. Changing temperature to 50° C.; 
3. Adding cellulase cocktails and ~-glucosidase and stirring at 
50° C.; and 
4. Withdrawing reaction mixture aliquots for glucose quanti-
fication at various time intervals. 
Example 2 
Effect oflncubation Time, CBD Concentration, and 
Buffer on Hydrolysis Rate 
To find more optimum CBD treatment times that would 
lead to a higher increase in hydrolysis rate, the 48 h incubation 
45 available on cellulose surface due to the presence of multiply-
bound CBDs, competitive adsorption between CBD and cel-
lulases occurs. No major difference was found between 0.5 
and 2 Yr. The lowest CBD concentration (0.14 vr) performed 
similarly to water, and the highest CBD concentration (4 Yr) 
50 performed similarly to the buffer. 
CBD Production for the CBD of Examples 3-8 
The CBD employed in Examples 3-6 was made as follows: 
Cel7 A was obtained from a mixture of cellulases from Tri-
choderma reesei and purified by means of anion exchange 
55 column chromatography using a HiPrep Q FF column. The 
purified protein was cleaved by proteolysis using papain and 
the cellulose binding domain (attached to the linker) was 
separated from the catalytic domain by centrifugation 
through a 30 kDa membrane and collected in the filtrate at a 
60 concentration of 125-175 µg/ml. 
65 
Example 3 
Effect of CBD Treatment Time 
Avicel (20 mg/ml) was incubated in buffer (NaOAc 50 mM 
pH 5.0) together with CBD (24 µg/ml) at 37° C. and under 
US 8,506,717 B2 
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gentle stirring in a 24 ml glass vial. The effect of treatment 
was investigated over various time periods (8 h, 13 h, 24 hand 
48 h). 
Hydrolysis of cellulose was performed on the CBD treated 
Avicel (20 mg/ml) by addition of cellulases (24 µI/ml, 3.4 5 
mg/ml total protein, 3.8 FPU/ml) and ~-glucosidase (15 
U/ml) to the mixture and the reaction was carried out at 50° C. 
Glucose production was monitored by the DNS assay at vari-
ous intervals (1 h, 2.5 h and 4 h). Controls were run on dry 
Avicel (no CBD treatment) and on samples incubated in 
10 buffer only (for 1 h, 13 hand 48 h). 
10 
48 µg/ml) at 37° C. and under gentle stirring for 18 h in a 24 
ml glass vial. The CBD adsorbed onto cellulose was removed 
by heating up the cellulose (recovered by centrifugation) in 
1.1 % SDS solution, followed by multiple washings with 
EtOH (75%) and water. 
Hydrolysis of cellulose was performed on CBD treated and 
washedAvicel by addition of cellulases (24 µI/ml, 3.4 mg/ml 
total protein, 3.8 FPU/ml) and ~-glucosidase (15 U/ml) to a 
solution of cellulose (20 mg/ml) in buffer (NaOAc 50 mM pH 
5.0) and the reaction was carried out at 50° C. Glucose pro-
duction was monitored by the DNS assay at various intervals 
(1 hand 2.5 h). 
The CBD removal procedure had a detrimental effect on 
cellulose hydrolysis, as the amount of glucose produced was 
The incubation in buffer was found to be beneficial to the 
hydrolysis, as a higher glucose concentration was obtained 
already after 1 h incubation compared to hydrolysis on dry 
cellulose. The effects were more pronounced after a 13 h 
incubation, and no further increase was obtained up to 48 h. 
Incubation of Avicel in CBD gave a surprising and unex-
pected increase compared to the buffer alone (20-35% ). The 
CBD treatment reached a maximum effect after 13 h incuba-
tion. The results are shown in FIG. 7. 
15 significantly lower than that obtained after treatment with 
CBD with no removal, and slightly lower than that obtained 
after incubation in buffer only. The results are shown in com-
bination with the results of Example 5 at FIG. 9. 
Example 4 
Effect of CBD Concentration 
Avicel (20 mg/ml) was incubated in buffer (NaOAc 50 mM 
pH 5.0) together with CBD at various concentrations (3.4, 
6.9, 12, 24, 48 and 96 µg/ml) at 37° C. and under gentle 
stirring for 18 h in a 24 ml glass vial. Hydrolysis of cellulose 
was performed on CBD treatedAvicel (20 mg/ml) by addition 
ofcellulases (24 µI/ml, 3.4 mg/ml total protein, 3.8 FPU/ml) 
and ~-glucosidase (15 U/ml) to the mixture and the reaction 
was carried out at 50° C. Glucose production was monitored 
by the DNS assay at various intervals (1 h, 2.5 hand 4 h). The 
effect of CBD incubation on cellulose hydrolysis was found 
to be better at 7 µg/ml, up to 48 µg/ml, whereas higher con-
centrations gave a lower increase in glucose production, espe-
cially at 96 µg/ml where the treatment was less efficient than 
in buffer only. The results are shown in FIG. 8. 
Example 5 
Effect of Sequential Addition 
20 Example 7 
Effect oflncubation Temperature 
A vice! (20 mg/ml) was incubated in buffer (NaOAc 50 mM 
25 pH 5.0) together with CBD at various concentrations (24 and 
48 µg/ml) and temperatures ( 45 and 50° C.) and under gentle 
stirring for 24 h in a 24 ml glass vial. 
Hydrolysis of cellulose was performed on CBD treated 
Avicel (20 mg/ml) by addition of cellulases (24 µI/ml, 3.4 
30 mg/ml total protein, 3.8 FPU/ml) and ~-glucosidase (15 
U/ml) to the mixture and the reaction was carried out at 50° C. 
Glucose production was monitored by the DNS assay at vari-
ous intervals (1 h, 2.5 hand 4 h). 
Treatment with CBD at 45° C. led to higher glucose pro-
35 duction compared to 37° C., whereas 50° C. showed lower 
glucose production compared to 45° C. At 50° C., the CBD 
concentration effect differed from the one at 37° C.: CBD 
incubation at 24 µg/ml was less efficient than at 48 µg/ml. In 
addition, CBD incubation at 48 µg/ml performed less good 
40 than at 45° C. The results are shown in FIGS. 10 and 11. 
Avicel (30 mg/ml) was incubated in buffer (NaOAc 50 mM 
pH 5.0) at 37° C. and under gentle stirring for 18 h in a 24 ml 
glass vial, followed by the addition of a CBD solution in same 45 buffer ( 48 µg/ml), corresponding to a final concentration of 
Avicel of 20 mg/ml. The mixture was stirred for another 12 h 
Example 8 
Treatment of Switchgrass with CBD 
The treatment based on cellulose-binding domain (CBD) 
from cellobiohydrolase I (Cel7 A) from Trichoderma reesei 
was applied to lignocellulosic materials (switchgrass), fol-
lowed by the addition of cellulases to the CBD treatment 
mixture to perform hydrolysis. This led to an increase in 
lignocellulose enzymatic hydrolysis compared to no treat-
at 37° C. 
Hydrolysis of cellulose was performed on CBD treated 
Avicel (20 mg/ml) by addition of cellulases (24 µI/ml, 3.4 
mg/ml total protein, 3.8 FPU/ml) and ~-glucosidase (15 50 
U/ml) to the mixture and the reaction was carried out at 50° C. 
Glucose production was monitored by the DNS assay at vari-
ous intervals (1 hand 2.5 h). 
The sequential addition of CBD after first incubating in 
buffer only led to higher conversion than simultaneous incu- 55 
bation in buffer and addition of CBD. This effect was more 
ment with CBD ("dry sample") prior to hydrolysis, as mea-
sured as the amount of reducing ends produced over time. 
Briefly, switchgrass (20 mg/ml) was incubated at 45° C. in 
sodium acetate buffer (pH 5.0, 50 mM) supplemented with 
CBD (24 µg/ml) and under gentle stirring in a 24 ml glass vial 
for 16 h. The hydrolysis was performed on CED-treated 
switchgrass (20 mg/ml) by addition of cellulases (24 µI/ml, 
3.4 mg/ml total protein, 3.8 FPU/ml) and ~-glucosidase (15 
pronounced at higher degrees of conversion (about 35% 
higher glucose production compared to incubation in buffer 
only after 2.5 h hydrolysis). The results are shown in combi-
nation with the results of Example 6 at FIG. 9. 60 U/ml) to the mixture and the reaction was carried out at 50° C. 
Example 6 
Effect of CBD Removal 
Avicel (20 mg/ml) was incubated in buffer (NaOAc 50 mM 
pH 5 .0) together with CBD at various concentrations ( 6.9 and 
The effect of CBD treatment was investigated by measuring 
the amount of reducing ends produced over time (as equiva-
lents of glucose) using the DNS assay at various intervals (1 
h, 2.5 h, 4 hand6 h). Controls were run on dry switchgrass (no 
65 CBD treatment), dry switchgrass with simultaneous addition 
of CBD and cellulases and on samples incubated in buffer 
only (for 16 h). 
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The incubation in buffer was found to be slightly beneficial 
for hydrolysis, as a higher reducing end concentration was 
obtained after 16 h incubation compared to hydrolysis on dry 
switchgrass (maximum 25% increase after 1 h conversion). 
The effects were much more pronounced when CBD was 5 
present in the incubation mixture (up to 65% increase in 
reducing end concentration after 2.5 h conversion compared 
to dry sample). After 16 h incubation of switchgrass with 
CBD, the reducing end concentration presented a substantial 
increase compared to the one obtained after incubation in 10 
buffer alone ( 40-45% after 2.5 h conversion). Simultaneous 
addition ofCBD and cellulases did not yield any difference in 
conversion compared to the dry sample. The results are shown 
in FIG.12. 
12 
index of cellulose was measured from X-ray diffraction data 
using an analytical method described at, for example, Bansal 
et al., Multivariate statistical analysis of X-ray data from 
cellulose: A new method to determine degree of crystallinity 
and predict hydrolysis rates. Bioresource Technol., 101, 
4461-4471. 
Cellulose Pretreatment and Hydrolysis 
Cellulose-binding domains were added in various amounts 
(up to 12 µg.mg- 1) to cellulose (Avicel or fibrous cellulose, 
total 56 mg, 40 mg.mL- 1) in sodium acetate buffer (50 mM, 
pH 5) in a glass vial (containing a stir bar). The mixture was 
incubated for 15 hat various temperatures in a shaker incu-
bator at 170 rpm and was then diluted with buffer to lower 
cellulose concentration to 20 mg.mL- 1 for subsequent 
Example 9 
CBD Treatment of Avicel and Fibrous Cellulose 
from Cotton Linters 
15 hydrolysis. Hydrolysis was initiated after the pretreatment 
step by adding cellulases (24 mL.L-1, 3.4 g.L- 1 total protein) 
and ~-glucosidase (15 kU.L- 1 ) to the reaction mixture, and 
was carried out at 50° C. and 170 rpm. The course of the 
reaction was monitored by performing DNS assay on small 
20 aliquots taken after 30 min, 1 h, and 2.5 has described in, for 
example, Hall et al., 2010. Cellulose crystallinity-a key 
predictor of the enzymatic hydrolysis rate. Febs Journal, 277, 
1571-1582. 
Avicel PH-101, fibrous cellulose from cotton !inters 
(Sigma C6288, medium), cellulases from Trichoderma reesei 
(159 FPU.mL- 1)), and ~-glucosidase (from almonds, 2.32 
U.mg- 1)) were obtained from Sigma (St Louis, Mo., USA). 
The (micro) BCA protein assay kit and the Coomassie (Brad- 25 
ford) protein assay kit were obtained from Thermo Fischer 
Scientific (Rockford, Ill., USA). Papain was obtained from 
Fluka as lyophilized powder from Carica papaya (9.84 
U.mg- 1). Centrifugal devices with polyethersulfone mem-
branes were from Pall Life Sciences (Ann Arbor, Mich., 30 
USA). All experiments and assays were run at least in dupli-
cate. 
For the thermo stability experiment, cellulases and catalytic 
domains were incubated at 50° C. for 15 h and then added 
(300 µg.mL- 1 and 125 µg.mL-1, resp.) to a cellulose mixture 
(Avicel, 20 mg.mL- 1 in sodium acetate buffer, 50 mM, pH 5) 
that had been incubated at 50° C. for 1 h at 900 rpm. The 
hydrolysis was run at 50° C. and 900 rpm and the conversion 
was monitored after 6 hand 22 h by performing DNS assay on 
the supernatant. 
Enzyme Adsorption Experiments 
Cel7 A Purification A vice! samples (20 mg.mL- 1) in sodium acetate buffer (50 
mM, pH 5) were incubated at 50° C. for 1 hat 900 rpm, and 
35 then cooled down to 4° C. Cellulases (which had been incu-
bated in sodium acetate buffer at 50° C. for 15 h or stored at 
Cel7 A was purified from Trichoderma reesei cellulase 
cocktail by means of anion-exchange chromatography as 
published in, for example, Hall et al., 2010. Cellulose crys-
tallinity-a key predictor of the enzymatic hydrolysis rate. 
Febs Journal, 277, 1571-1582. Purity was confirmed by SDS-
PAGE. After purification, Cel7 A buffer was exchanged to 
sodium acetate buffer (50 mM, pH 5) using a polyethersul- 40 
fone membrane (molecular weight cut-off of 10 kDa) in a 
Macrosep device. 
Cellulase Proteolysis and CBD Isolation 
Cellulase cleavage using papain was adapted from proce-
dures published at, for example, Lemos et al., 2000. A simple 45 
method to separate cellulose-binding domains of fungal cel-
lulases after digestion by a protease. Biotechnology Letters, 
22, 703-707. Cellulase preparation (mixture from Tricho-
derma reesei) was diluted (5x) in sodium acetate buffer (50 
mM, pH 5) and concentrated in a Jumbosep centrifugal 50 
device (polyethersulfone membrane, molecular weight cut-
off of 30 kDa) to remove smaller molecules. Papain was 
activated in ammonium acetate buffer (50 mM, pH 6) at 30° 
C. and 170 rpm for 30 min and added to the cellulase solution 
(w/w 1:5, v/v 1:5). The digestion was performed at 30° C. for 55 
2 h (completion checked via SDS-PAGE). The mixture was 
then filtered through 30 kDa membrane and both filtrate and 
concentrate were analyzed for protein content using the micro 
BCAassay. 
4 ° C. since purchase) were added in various amounts and the 
mixture was further agitated for 30 min at 4° C. After cen-
trifugation, the supernatant was collected and protein content 
analysis was performed using the BCA protein assay kit. 
Results of Example 9 
Cellulase Proteolysis and CBD Isolation 
Both cellulase mixture (endoglucanases and exogluca-
nases) and purified cellobiohydrolase Cel7A from Tricho-
derma reesei were used in the proteolysis experiment using 
papain as cleaving agent. Cleavage was complete in both 
cases (as observed by the disappearance of full-length 
enzymes) and isolation of CBD through filtration yielded a 
mixture ofCBDs or pure CBDcenA' and corresponding cata-
lytic domains (CDs) from the retentate could be observed by 
SDS-PAGE as shown in FIG. 13. 
Cellulose Incubation with CBDs and Crystallinity 
In Example 9, vigorous stirring was provided using a 
shaker incubator and the addition of a stir bar to the system. 
The high crystalline content of A vice! (CrI 60%) and fibrous 
cellulose (CrI 72%) allows for monitoring of changes occur-
ring during pretreatment. After pretreatment of cellulose with 
CBDs in buffer at 42° C. for 15 h under vigorous agitation, the 
samples were collected and their crystallinity content was 
X-Ray Diffraction and Crystallinity Measurement 60 assessed by X-ray diffraction (XRD), while the supernatant 
was analyzed for the presence of soluble reducing ends. No 
reducing ends were released from the buffer control sample. 
While the amount of soluble reducing ends obtained with 
X-ray diffraction patterns of cellulose samples (buffer and 
CBD pretreated) obtained after freeze-drying (at -55° C. and 
0.03 mbar for 16 hours) were recorded with an X'Pert PRO 
X-ray diffractometer (PANanalytical BY, Almelo, the Neth-
erlands) at room temperature from !Oto 35° C., usingCu/Ka1 65 
irradiation (1.54 A) at 45 kV and 40 mA. The scan speed was 
0.021425°.s- 1 with a step size of0.0167°. The crystallinity 
CBDs was very low ( <120 µg.mL-1, starting from cellulose 
concentration at 20 mg.mL- 1 ), it was consistent and above 
buffer background. Family I CBDs most likely do not have 
any hydrolytic activity; rather, small soluble oligomers were 
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released from the cellulose surface upon binding/processing 
of CBDs. No disrupting activity could be observed e.g., no 
agglomerate formation nor faster precipitation without 
CBDs ). After incubation in buffer only (control), the crystal-
linity of both types of cellulose (Avicel and fibrous) was 
shown to have slightly increased as shown in Table 3 below. 
TABLE3 
Effect of 15 h incubation with buffer and cellulose-binding domains 
on cellulose crystallinity (Cr!) as determined via X-Ray diffraction. 
Cellulose substrate 
Cr! on dry sample (untreated) 
CrI after incubation in buffera 
Cr! after pretreatruent with CBDs 
CrI after pretreatment with CBDcenAb 
CrI after incubation with CDcenAb 
aSodium acetate (pH 5.0, 50 mM). 
hr.,onger incubation times (>48 h). 
n.d. Not determined 
Avicel 
60% 
65% 
58% 
53-56% 
64% 
Fibrous 
cellulose 
72% 
74% 
68% 
n.d. 
n.d. 
While not wishing to be bound to any particular theory, the 
crystallinity increase could be due to a phenomenon referred 
to as "recrystallization" described in, for example, Ouajai, S., 
Shanks, R. A., 2006. Solvent and enzyme induced recrystal-
lization of mechanically degraded hemp cellulose. Cellulose, 
13, 31-44. The increase (from 60% up to 65-66% on average 
for Avicel, and 72% up to 74% for fibrous cellulose) is not 
likely attributable to the removal of non-crystalline material 
from cellulose, as no soluble reducing ends were released in 
the buffer control sample. Also, the freeze-drying does not 
have effect on cellulose crystallinity so that only extended 
incubation in buffer resulted in such a dramatic increase in 
crystallinity index (additionally, both buffer and CBD pre-
treated samples were freeze-dryed before XRD analysis). The 
use of CBDs (up to 10 µg.mg- 1 at 40 mg.mL- 1 cellulose in a 
typical pretreatment step) resulted in a different trend, as it not 
only prevented the substrate from recrystallizing, but also 
reduced the initial crystallinity of cellulose. Avicel crystallin-
ity reached 58% after incubation with a mixture of CBDs, 
while fibrous cellulose crystallinity reached 68%, a signifi-
cant drop from the crystallinity indices obtained after incu-
bation in buffer only. When cellulose was incubated with pure 
CBDs from cellobiohydrolase I Cel7 A (CBDcenA) over 
extensive periods ofincubation (>48 h), an even higher reduc-
tion in crystallinity was obtained with Avicel (down to 53%, 
as shown in FIG. 14. 
Though the difference between the spectra appears limited 
14 
Hydrolysis of CBD Pretreated Cellulose 
Cellulose incubated with CBDs for 15 h was hydrolyzed by 
adding cellulases (supplemented with ~-glucosidase) to the 
pretreatment mixture (one-pot process). The pretreatment of 
Avicel at 40 mg.mL- 1 affected the conversion as shown in 
FIG. 15a, as the amount of sugar released from CBD pre-
treated samples (reduced crystallinity of 58%, Table 3) was 
25% higher than that released from buffer pretreated samples 
(increased crystallinity of 65%, Table 3) after 30 minhydroly-
10 sis time (7.9 mg.mL- 1 vs. 6.3 mg.mL- 1 glucose resp.). Such 
an increase could potentially lead to a reduction in cost of the 
enzymatic process which is one of the major cost contributing 
factors in biofuel production from biomass. 
15 
20 
Interestingly, no significant difference in rate compared to 
incubation in buffer only could be monitored at 20 mg.mL- 1 
Avicel concentration when using the mixture of CBDs, even 
when the CBD concentration was increased to 12 µg.mg- 1 
(FIG. 15a). Similar behavior was observed with fibrous cel-
lulose: the incubation at 20 mg.mL- 1 FC concentration did 
not give a significant change in conversion compared to the 
incubation in buffer only (FIG. 15b), whereas 23% increase 
was obtained after incubation with CBDs at 40 mg.mL- 1 FC 
compared to buffer incubation (relating to 68% vs. 7 4% crys-
tallinity resp., Table 3). The much slower rate obtained in the 
25 conversion ofFC compared to Avicel can be explained in part 
by higher initial crystallinity (72% vs. 60% for untreated 
samples; however, surface area and particle size may also 
contribute). 
It was observed that pretreatment with CBDs for 8 h 
30 instead of > 15 h did not lead to significant change in the 
amount of glucose released during the hydrolysis step com-
pared to the buffer incubated sample. Incubation with CBDs 
opens up new possibilities in cellulose pretreatment and 
avoids the use of harsh conditions (such as high temperature 
35 or acid concentration) or isolation of cellulose from the pre-
treatment mixture before hydrolysis with cellulases. 
The exact amino acid sequence of family I CBDs seems 
less important for rate improvement: pretreatment with 
homogeneous CBDcenA yielded results comparable to those 
40 with a mixture of CBDs: increased rates i) after pretreatment 
at 42° C. (and also 37° C.) with CBDcenA compared to buffer 
only, ii) after 30 min hydrolysis (7.5 mg.mL- 1 vs. 6 mg/ 
mL- 1 ): 25% increase in glucose concentration, and iii) under 
similar conditions (34 mg.mL- 1 Avicel concentration com-
45 pared to 40 mg.mL- 1 with the mixture). However, pretreat-
ment conducted at lower cellulose concentration (20 mg. 
mL- 1) also yielded faster conversion, as there was only a 
minor drop in rate in the case of the sample pretreated at 20 
mg.mL- 1 (compared to 40 mg.mL- 1 as shown in FIG.16). 
While not wishing to be bound to any particular theory 
desorption of CBDs upon dilution performed prior to the 
hydrolysis might be responsible for the higher rates after 
pretreatment with a CBD mixture at 40 mg.mL- 1 (compared 
to no improvement at 20 mg.mL- 1 ). Such desorption would 
55 liberate binding spots for cellulases on the cellulose surface 
and thus increase overall hydrolysis rate. Though incubation 
in buffer led to an increase rather than decrease in overall 
cellulose crystallinity (Table 3), it provided hydration of the 
sample and a nearly two-fold increase in hydrolysis rate was 
to one portion of the XRD patterns, the analytical method 50 
described above for interpretation of XRD data of cellulose 
allowed accurate determination of the crystallinity index. The 
drop in intensity observed at a Bragg angle of 22.5° ((200) 
plane) accounts for the overall reduction in crystallinity. 
Thus, CBDs from Trichoderma reesei (belonging to family I 
CBD, along with CBDs of cellulases from Phanerochaete 
chrysosporium or Penicillium janthinellum ), though not cata-
lytically active with cellulose, had a strong effect on the 
cellulose structure, as overall crystallinity was significantly 
reduced. Interestingly, the crystal plane (200) seems to be the 
only one affected by these changes as illustrated in FIG. 14. 
Overall, CBDs are responsible for splitting of intermolecular 
hydrogen bonds to such an extent that the cellulose crystal-
linity is noticeably reduced. While not wishing to be bound to 
any particular theory this most likely proceeds via a dynamic 
process (processive motion on cellulose surface required), 
which is still poorly understood. 
60 observed compared to employing dry cellulose without pre-
treatment. Thus, the increase in rate obtained after pretreat-
ment with CBDs may be a combination of hydration effect 
from the buffer and reduction in crystallinity from CBDs. 
Increased CBD concentration during pretreatment led to 
65 enhanced production of glucose in the hydrolysis step as 
shown in FIG. 17. The present loading of 9 µg.mg- 1 is not 
saturating the surface since 150 µg.mg- 1 cellulase at a total 
US 8,506,717 B2 
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loading of 1230 µg.mg- 1 bind to the cellulose surface as 
shown by Hall, et al, 2010. Cellulose crystallinity-a key 
predictor of the enzymatic hydrolysis rate. Febs Journal, 277, 
1571-1582. And there was no saturation of Avicel employing 
up to 470 µg.mg- 1 CBDcenA (corresponding to 49 µg.mg 
bound CBD) as shown by Stahlberg, et al., 1991. A New 
Model for Enzymatic-Hydrolysis of Cellulose Based on the 
2-Domain Structure ofCellobiohydrolase-I. Bio-Technology, 
9, 286-290. 
16 
resp.). It can thus be concluded thatthe observed thermolabil-
ity of cellulases is mostly due to loss of catalytic activity 
ratherthan binding capacity, as pretreatment of cellulose with 
CBDs can be performed at 50° C. 
CBDcenA is a small peptide (37 residues) and made up of 
an irregular triple-stranded anti parallel ~-sheet as reported in, 
for example, Kraulis, et al., 1989. Determination of the 3-Di-
mensional Solution Structure of the C-Terminal Domain of 
In the absence of stirring during pretreatment (but when 10 
shaking was still provided), overall reaction rates were 40% 
lower and incubation with CBDs surprisingly did not lead to 
Cellobiohydrolase-I from Trichoderma-Reesei-a Study 
Using Nuclear Magnetic-Resonance and Hybrid Distance 
Geometry Dynamical Simulated Annealing. Biochemistry, 
28, 7241-7257. While not wishing to be bound to any particu-
lar theory it may be that the stability at higher temperatures 
may be at least in part due to its compact structure and/or the 
two disulfide bridges. 
an increase in glucose concentration as shown in FIG. 18. The 
use of stir bars 72% as large as the inner diameter of the vials 
resulted in up to 1.5 fold higher conversion levels in buffer, a 15 
positive effect of CBD incubation, but reduced reproducibil- Conclusions 
ity (most likely due to inhomogeneous stirring owing to geo-
metric constraints in the reaction vial). Henceforth, stir bars 
Cellulose-binding domains had impacted cellulose struc-
of 55% of inner vial diameter were used. Likely, the lack of 
continual convection in the absence of stirring prevents lateral 20 
displacement of CBD molecules and thus limits their effec-
tiveness, given the absence of catalytic events as a potential 
energy source for CBD movement along the cellulose sur-
face. 
ture upon incubation. The crystallinity of different types of 
cellulose (microcrystalline and fibrous) was reduced after 
pretreatment with CBDs, rendering the substrates less recal-
citrant to enzymatic hydrolysis, and an increase up to about 
25% in glucose concentration during hydrolysis was 
obtained. These surprising and unexpected results show that 
cellulose binding domains can be used as a pretreatment 
Surprisingly and unexpectedly, preincubation of cellulose 
with CBDs lowered its index of crystallinity and resulted in 
higher glucose concentration in the subsequent hydrolysis 
reaction. Also, it was observed that simultaneous addition of 
CBDs to non-pretreated cellulose samples did not show any 
improvement in conversion levels. Thus, the use of CBDs in 
a pretreatment step rather than a one-step process combining 
addition ofCBDs and full-length enzymes is surprisingly and 
unexpectedly effective. While not wishing to be bound to any 
particular theory, it may be that simultaneous addition of 
CBDs to the hydrolysis mixture prevents reduction of crys-
tallinity by CBDs due to competitive binding with cellulases 
and/or hydrolysis of cellulose by cellulases. 
Thermo stability of CBDs 
Similarly to the conditions used in the enzymatic hydroly-
25 method for cellulosic material. The inventive pretreatment 
employs biological molecules and relatively mild conditions 
instead of harsh chemicals and conditions. In addition, the 
inventive pretreatment may be used in a manner such that it 
does not require a change of solvent. Moreover, the binding 
30 capacity ofCBDs is retained after extensive incubation at 50° 
C. while there is significant loss of catalytic activity. 
Figure Legends 
FIG. 1 SDS-PAGE of purified cel7 A from Trichoderma 
reesei and cel7 A catalytic domain after papain cleavage. Lane 
35 1: ladder, lane 2: purified cel7A, lane 3: catalytic domain 
(CD) in concentrate after filtration through 30 kDa membrane 
(Coomassie staining). 
FIG. 2 Enzymatic hydrolysis of Avicel after CBD treat-
ment (numbers refer to cellulose sample from Table 2). Reac-
40 tions were run as follows: 20 mg/ml Avicel, 50 mM NaOAc 
pH 5, 50° C. (#3 and 4 were used as freeze-dried powder, 
generated for X-ray diffraction analysis). All samples were 
incubated 1 hat 50° C. before addition of the enzyme to the 
reaction mixture. 
sis of pretreated cellulose, pretreatment with CBDs was also 
performed at 50° C. After 15 h pretreatment at 50° C. and 
hydrolysis for 30 min, it was observed that conversion was 
only slightly lower than after pretreatment at 42° C. indicat-
ing that CBDs can be considered relatively thermostable. This 
observation was confirmed with binding experiments, where 45 
full-length cellulases were shown to bind similarly to Avicel 
after 15 h ofincubation at 50° C., compared to storage at 4 ° C. 
FIG. 3. CBD incubation time effects (after reported time 
period, enzymes were added to the mixture of CBD and 
Avicel and hydrolysis was monitored by measuring glucose 
content, expressed as conversion%). as shown in Table 4 below. 
TABLE4 
Effect of 15 h incubation at 50° C. on catalytic activity of cellulases and catalytic 
domains (CDs) and binding of cellulases onAvicel (compared to standard storage at 4° C.). 
Incubation Activity (Glucose concentration in mg · mL -l) Binding capacity 
temperature Cellulase cocktail CDs (bound cellulases µg · mg- 1) 
40 c. After 6 h: 5.6 After 6 h: 1.2 37.3 (total added 90 µg · mg-1) 
After 22 h: 8.2 After 22 h: 2.2 38.4 (total added 150 µg · mg- 1) 
50° c. After 6 h: 3.2 After 6 h: 0.5 41.4 (total added 90 µg · mg-1) 
After 22 h: 3.6 After 22 h: 0. 7 44.0 (total added 150 µg · mg- 1) 
The activity of cellulases, however, was affected by the 
same incubation period at 50° C. (1.8 fold decrease after 6 h 
hydrolysis, up to 2.3 after 22 h). The catalytic activity of CDs 
was even more reduced after incubation at 50° C. (2.4 and3.1 
fold decrease in glucose concentration after 6 h and 22 h 
FIG. 4. Effect of buffer incubation on hydrolysis rate com-
pared to CBD incubation (13 h). Avicel was incubated in CBD 
65 solution or in buffer for 13 h (also 1 h in buffer). Cellulases 
were then added to the reaction mixture and glucose content 
was monitored for up to 2.5 h. 
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FIG. 5. Effect of buffer incubation time on hydrolysis rates. 
Avicel was incubated in buffer over various periods of time. 
Cellulases were then added to the reaction mixture and glu-
cose content was monitored for up to 4 h. 
FIG. 6. CBD concentration optimization experiment (Vr 
represents the starting concentration). Graph b consists of the 
same data as graph a but for the lines connecting the data 
points. 
FIG. 7. The hydrolysis for various CBD treatment times. 
FIG. 8. The effect of various concentrations ofCDB. 10 
FIG. 9. The effect of sequential addition and CBD removal. 
FIG. 10. The effect of a 45° C. treatment. 
FIG. 11. The effect of a 50° C. treatment. 
FIG. 12. Production of reducing ends from switchgrass 
using cellulases and ~-glucosidase after treatment with CBD, 15 
treatment with buffer, no treatment with simultaneous addi-
tion of CBD and no treatment (dry sample). 
FIG. 13. SDS-PAGE before and after papain cleavage of 
cellulases. Lane 1: ladder, lane 2: cellulase cocktail from 
[;!:~~=~:~: ~~~~~tf:~~!~~~:i(~6~~~~~l~u~a~~~1::~~ 20 
purified Cel7 A after anion-exchange chromatography, lane 5: 
CD of purified Cel7A, lane 6: ladder, lanes 7 and 8: higher 
loading of cellulase cocktail from Trichoderma reesei after 
filtration through 30 kDa and corresponding CDs, lane 9: 
purified Cel7 A (lower loading). 25 
FIG. 14. XRD spectra for Avicel samples treated with 
CBDcenA (cellulose-binding domain from purified Cel7A), 
CDcenA (catalytic domain) or buffer. The spectral data have 
been normalized according to Bansal et al., 2010. Multivari-
ate statistical analysis of X-ray data from cellulose: A new 30 
method to determine degree of crystallinity and predict 
hydrolysis rates. Bioresource Technology, 101, 4461-4471. 1 
and 2 refer to duplicated experiments. 
FIG. 15a. Hydrolysis profile of Avicel after pretreatment 
with mixture of CBDs for 15 hat 42° C. (the hydrolysis was 35 
run at 50° C. and 20 mg.mL- 1 cellulose. The cellulose con-
centration refers to the actual concentration during pretreat-
ment). 
FIG. 15b. Hydrolysis profile offibrous cellulose (FC) after 
pretreatment with mixture of CBDs for 15 h at 42° C. (the 
hydrolysis was run at 50° C. and 20 mg.mL- 1 cellulose. The 40 
cellulose concentration refers to the actual concentration dur-
ing pretreatment). 
FIG. 16. Hydrolysis profile of Avicel after pretreatment 
with CBDcenA for 15 hat 42° C. (the hydrolysis was run at 
50° C. and 20 mg.mL - 1 cellulose. The cellulose concentration 45 
refers to the actual concentration during pretreatment). 
FIG. 17. Effect of various CBD concentrations in the pre-
treatment step (15 hat42° C.) on hydrolysis rate (the hydroly-
sis was run at 50° C. and 20 mg.mL- 1 cellulose. The cellulose 
concentration refers to the actual concentration during pre- 50 
treatment). 
FIG. 18. Effect of stir bar during pretreatment of cellulose 
with CBDs on hydrolysis rates. The pretreatment was run at 
42° C. for 15 h without stir bar (10 µg.mg- 1), or with large stir 
bars (7 .5 µg.mg- 1 ). The hydrolysis was run at 50° C. and 20 55 
mg.mL- 1 cellulose concentration. 
FIG.19.Amino acid sequences oftheCBD ofmajororgan-
isms. The sequences of FIG. 19 were identified via a BLAST 
search (http://blast.ncbi.nlm.nih.gov/Blast.cgi#) (Altschul 
SF, Gish W, Miller W, Myers E W, Lipman D J: Basic Local 
Alignment Search Tool. Journal of Molecular Biology 1990, 60 
215:403-410). The sequences were aligned using clustalW 
(Thompson J D, Higgins D G, Gibson T J: CLUSTAL W: 
improving the sensitivity of progressive multiple sequence 
alignment through sequence weighting, position-specific gap 
penalties and weight matrix choice. Nucleic Acids Res 1994, 65 
22(22):4673-4680). The names of enzymes and species, of 
which the sequences in FIG. 19 are a part of (according to the 
18 
number in the alignment xxl where xx denotes the number; 
e.g., the Trichoderma reesei Cel7 A CBD sequence is desig-
nated 111/1-36 outlined in FIG. 19 is number 1 in Table 5 
below). 
TABLES 
Number Enzyme (species) 
Cel7A [Trichoderma reesei] 
2 cellobiohydrolase I [Trichoderma viride] 
cellubiohydrolase I [Trichoderma sp. XSTl] 
4 bifunctional chitosanase-cellulase [Trichoderma viride] 
Cipl [Hypocrea jecorina] 
cellobiohydrolase I [Hypocrea virens] 
7 cellobiohydrolase [Hypocrea lixii] 
cellobiohydrolase I [Neolentinus lepideus] 
9 exocellobiohydrolase [Phanerochaete chrysosporium] 
10 endo-1,4-xylanase D [Penicilliumfuniculosum] 
11 endoglucanase [Aspergillusfumigatus Af293] 
12 xylanase/cellobiohydrolase [Penicilliumfuniculosum] 
13 cellobiohydrolase I [Penicillium occitanis] 
14 glycosyl hydrolase family 45 protein [Neosartoryafischeri 
NRRL 181] 
15 cellulose binding protein [Phanerochaete chrysosporium] 
16 CBHI [Volvariella volvacea] 
17 endo-1,4-beta-xylanase [Aspergillusfumigatus Af293] 
18 cellulose binding iron reductase [Coprinopsis cinerea 
okayama7#130] 
19 Acetyl xylan esterase [Hypocrea jecorina] 
20 cellulase [Irpex lacteus] 
21 endoglucanase IV [Trichoderma viride] 
22 endoglucanase IV [Trichoderma sp. SSL] 
23 endoglucanase 1 [Penicillium echinulatum] 
24 endoglucanase II [Trichoderma viride] 
25 endoglucanase III [Trichoderma viride] 
26 endoglucanase III [Hypocrea jecorina] 
27 endoglucanase II [Hypocrea jecorina] 
28 glycoside hydro lase family 5 [Nectria haematococca] 
29 glycosyl hydrolase family 61 [Glomerella graminicola Ml.001] 
30 cellulase [Irpex lacteus] 
31 endo-1,4-beta-xylanase C precursor 
[Phanerochaete chrysosporium] 
32 endoglucanase I [Penicillium oxalicum] 
33 endoglucanase I [Penicillium decumbens] 
34 cellulose binding protein [Talaromyces emersonii] 
35 cellulose-binding beta-glucosidase 
[Phanerochaete chrysosporium] 
36 Acetyl xylan esterase [Aspergillus fumigatus Af293] 
37 glycosyl hydrolase family 62 protein [Coprinopsis cinerea 
okayama7#130] 
38 Family 61 endoglucanase [Phanerochaete chrysosporium] 
39 Fungal cellulose binding domain protein [Aspergillus clavatus 
NRRLl] 
40 cellulase CEL7A [Lentinula edodes] 
41 exoglucanase [Verticillium albo-atrum VaMs.102] 
42 cellobiohydrolase II [Acremonium cellulolyticus Y-94] 
43 glycosyl hydrolase family 7 protein [Neosartoryafischeri 
NRRL 181] 
44 cellulase CEL6B [Lentinula edodes] 
The claimed subject matter is not to be limited in scope by 
the specific embodiments described herein. Indeed, various 
modifications of the invention in addition to those described 
herein will become apparent to those skilled in the art from 
the foregoing description. Such modifications are intended to 
fall within the scope of the appended claims. 
All references cited herein are incorporated herein by ref-
erence in their entirety to the extent that they are not incon-
sistent and for all purposes to the same extent as if each 
individual publication, patent or patent application was spe-
cifically and individually indicated to be incorporated by 
reference in its entirety for all purposes. 
The citation of any publication is for its disclosure prior to 
the filing date and should not be construed as an admission 
that the present invention is not entitled to antedate such 
publication by virtue of prior invention. 
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<160> NUMBER OF SEQ ID NOS, 44 
<210> SEQ ID NO 1 
<211> LENGTH, 36 
<212> TYPE, PRT 
SEQUENCE LISTING 
<213> ORGANISM: Trichoderma reesei 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from enzyme Cel7A 
<400> SEQUENCE, 1 
Thr Gln Ser His Tyr Gly Gln Cys Gly Gly Ile Gly Tyr Ser Gly Pro 
1 5 10 15 
Thr Val Cys Ala Ser Gly Thr Thr Cys Gln Val Leu Asn Pro Tyr Tyr 
20 25 30 
Ser Gln Cys Leu 
35 
<210> SEQ ID NO 2 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM: Trichoderma viride 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellobiohydrolase I 
<400> SEQUENCE, 2 
Thr Gln Ser His Tyr Gly Gln Cys Gly Gly Ile Gly Tyr Ser Gly Pro 
1 5 10 15 
Thr Val Cys Ala Ser Gly Thr Thr Cys Gln Val Leu Asn Pro Tyr Tyr 
20 25 30 
Ser Gln Cys Leu 
35 
<210> SEQ ID NO 3 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM, Trichoderma sp. XSTl 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellubiohydrolase I 
<400> SEQUENCE, 3 
Thr Gln Thr His Tyr Gly Gln Cys Gly Gly Ile Gly Tyr Ser Gly Pro 
1 5 10 15 
Thr Val Cys Ala Ser Gly Thr Thr Cys Gln Val Leu Asn Glu Tyr Tyr 
20 25 30 
Ser Gln Cys Leu 
35 
<210> SEQ ID NO 4 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM: Trichoderma viride 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from bifunctional 
chitosanase-cellulase 
<400> SEQUENCE, 
Thr Gln Thr His 
1 
Thr Val Cys Ala 
20 
Ser Gln Cys Leu 
35 
4 
Tyr 
5 
Ser 
Gly Gln Cys Gly Gly Ile Gly Tyr Ser Gly 
10 15 
Gly Thr Thr Cys Gln Val Leu Asn Glu Tyr 
25 30 
Pro 
Tyr 
20 
<210> SEQ ID NO 5 
<211> LENGTH, 33 
<212> TYPE, PRT 
21 
<213> ORGANISM: Hypocrea jecorina 
<220> FEATURE, 
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-continued 
<223> OTHER INFORMATION, part of sequence from Cipl 
<400> SEQUENCE, 5 
His Tyr Gly Gln Cys Gly Gly Ile Gly Tyr Ser Gly Pro Thr Val Cys 
1 5 10 15 
Ala Ser Gly Thr Thr Cys Gln Val Leu Asn Pro Tyr Tyr Ser Gln Cys 
20 25 30 
Leu 
<210> SEQ ID NO 6 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM: Hypocrea virens 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellobiohydrolase I 
<400> SEQUENCE, 
Thr Gln Thr His Tyr Gly Gln Cys Gly Gly Ile Gly Tyr Ser Gly Pro 
1 5 10 15 
Thr Gln Cys Val Ser Gly Thr Thr Cys Gln Val Leu Asn Pro Phe Tyr 
20 25 30 
Ser Gln Cys Leu 
35 
<210> SEQ ID NO 7 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM, Hypocrea lixii 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellobiohydrolase 
<400> SEQUENCE, 7 
Thr Gln Thr His Tyr Gly Gln Cys Gly Gly Thr Gly Trp Thr Gly Pro 
1 5 10 15 
Thr Arg Cys Ala Ser Gly Phe Thr Cys Gln Val Leu Asn Pro Phe Tyr 
20 25 30 
Ser Gln Cys Leu 
35 
<210> SEQ ID NO 8 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM, Neolentinus lepideus 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from tcellobiohydrolase I 
<400> SEQUENCE, 8 
Thr Gln Thr Lys Tyr Gly Gln Cys Gly Gly Gln Gly Tyr Ser Gly Pro 
1 5 10 15 
Thr Val Cys Ala Ser Gly Ser Thr Cys Gln Thr Ser Asn Pro Tyr Tyr 
20 25 30 
Ser Gln Cys Leu 
35 
<210> SEQ ID NO 9 
<211> LENGTH, 34 
<212> TYPE, PRT 
22 
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<213> ORGANISM: Phanerochaete chrysosporium 
<220> FEATURE, 
-continued 
<223> OTHER INFORMATION, part of sequence from exocellobiohydrolase 
<400> SEQUENCE, 9 
Ser Glu Trp Gly Gln Cys Gly Gly Ile Gly Trp Thr Gly Pro Thr Thr 
1 5 10 15 
Cys Val Ser Gly Thr Thr Cys Thr Val Leu Asn Pro Tyr Tyr Ser Gln 
20 25 30 
Cys Leu 
<210> SEQ ID NO 10 
<211> LENGTH, 33 
<212> TYPE, PRT 
<213> ORGANISM: Penicillium funiculosum 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endo-1,4-xylanase D 
<400> SEQUENCE, 10 
His Trp Gly Gln Cys Gly Gly Ile Gly Trp Ser Gly Pro Thr Ile Cys 
1 5 10 15 
Val Ser Pro Tyr Thr Cys Gln Val Leu Asn Pro Tyr Tyr Ser Gln Cys 
20 25 30 
Leu 
<210> SEQ ID NO 11 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM, Aspergillus fumigatus Af293 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endoglucanase 
<400> SEQUENCE, 11 
Thr Gln Thr His Tyr Gly Gln Cys Gly Gly Gln Gly Trp Thr Gly Pro 
1 5 10 15 
Thr Ala Cys Ala Ser Pro Tyr Thr Cys Gln Val Leu Asn Pro Trp Tyr 
20 25 30 
Ser Gln Cys Leu 
35 
<210> SEQ ID NO 12 
<211> LENGTH, 34 
<212> TYPE, PRT 
<213> ORGANISM: Penicillium funiculosum 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from 
xylanase/cellobiohydrolase 
<400> SEQUENCE, 12 
Ala His Trp Gly Gln Cys Gly Gly Gln Gly Trp Thr Gly Pro Thr Thr 
1 5 10 15 
Cys Ala Ser Gly Thr Thr Cys Thr Val Val Asn Pro Tyr Tyr Ser Gln 
20 25 30 
Cys Leu 
<210> SEQ ID NO 13 
<211> LENGTH, 33 
<212> TYPE, PRT 
<213> ORGANISM: Penicillium occitanis 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellobiohydrolase I 
<400> SEQUENCE, 13 
24 
US 8,506,717 B2 
25 
-continued 
His Trp Gly Gln Cys Gly Gly Gln Gly Trp Thr Gly Pro Thr Thr Cys 
1 5 10 15 
Val Ser Gly Thr Thr Cys Thr Val Val Asn Pro Tyr Tyr Ser Gln Cys 
20 25 30 
Leu 
<210> SEQ ID NO 14 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM, Neosartorya fischeri NRRL 181 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from glycosyl hydrolase family 
45 protein 
<400> SEQUENCE, 14 
Thr Gln Thr Leu Tyr Gly Gln Cys Gly Gly Ser Gly Trp Thr Gly Pro 
1 5 10 15 
Thr Ala Cys Ala Ser Gly Ala Thr Cys Lys Val Leu Asn Ser Tyr Tyr 
20 25 30 
Ser Gln Cys Leu 
35 
<210> SEQ ID NO 15 
<211> LENGTH, 31 
<212> TYPE, PRT 
<213> ORGANISM: Phanerochaete chrysosporium 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellulose binding protein 
<400> SEQUENCE, 15 
Trp Gly Gln Cys Gly Gly Ile Gly Tyr Thr Gly Pro Thr Val Cys Ala 
1 5 10 15 
Ser Gly Phe Thr Cys His Val Leu Asn Pro Tyr Tyr Ser Gln Cys 
20 25 30 
<210> SEQ ID NO 16 
<211> LENGTH, 30 
<212> TYPE, PRT 
<213> ORGANISM: Volvariella volvacea 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from CBHI 
<400> SEQUENCE, 16 
Gly Gln Cys Gly Gly Ile Gly Tyr Thr Gly Pro Thr Thr Cys Ala Ser 
1 5 10 15 
Pro Thr Thr Cys His Val Leu Asn Pro Tyr Tyr Ser Gln Cys 
20 25 30 
<210> SEQ ID NO 17 
<211> LENGTH, 33 
<212> TYPE, PRT 
<213> ORGANISM, Aspergillus fumigatus Af293 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endo-1,4-beta-xylanase 
<400> SEQUENCE, 17 
Lys Trp Gly Gln Cys Gly Gly Ile Gly Trp Thr Gly Pro Thr Thr Cys 
1 5 10 15 
Val Ser Gly Thr Thr Cys Gln Lys Leu Asn Asp Trp Tyr Ser Gln Cys 
20 25 30 
Leu 
<210> SEQ ID NO 18 
26 
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<211> LENGTH, 36 
<212> TYPE, PRT 
27 
-continued 
<213> ORGANISM, Coprinopsis cinerea okayama7#130 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellulose binding iron 
reductase 
<400> SEQUENCE, 
Thr Gln Thr Ile 
1 
Thr Val Cys Ala 
20 
Ser Gln Cys Leu 
35 
18 
Tyr 
5 
Gly 
<210> SEQ ID NO 19 
<211> LENGTH, 36 
<212> TYPE, PRT 
Gly Gln Cys Gly 
Gly Ser Arg Cys 
25 
<213> ORGANISM: Hypocrea jecorina 
<220> FEATURE, 
Gly Thr Gly Tyr Ser Gly Pro 
10 15 
Lys Gln Val Asn Pro His Phe 
30 
<223> OTHER INFORMATION, part of sequence from Acetyl xylan esterase 
<400> SEQUENCE, 19 
Thr Gln Thr His Trp Gly Gln Cys Gly Gly Gln Gly Trp Thr Gly Pro 
1 5 10 15 
Thr Gln Cys Glu Ser Gly Thr Thr Cys Gln Val Ile Ser Gln Trp Tyr 
20 25 30 
Ser Gln Cys Leu 
35 
<210> SEQ ID NO 20 
<211> LENGTH, 35 
<212> TYPE, PRT 
<213> ORGANISM, Irpex lacteus 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellulase 
<400> SEQUENCE, 20 
Thr Ala Ala Gln Trp Ala Gln Cys Gly Gly Met Gly Phe Thr Gly Pro 
1 5 10 15 
Thr Val Cys Ala Ser Pro Phe Thr Cys His Val Leu Asn Pro Tyr Tyr 
Ser Gln Cys 
35 
20 25 30 
<210> SEQ ID NO 21 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM: Trichoderma viride 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endoglucanase IV 
<400> SEQUENCE, 21 
Thr Gln Thr Leu Tyr Gly Gln Cys Gly Gly Ser Gly Tyr Ser Gly Pro 
1 5 10 15 
Thr Arg Cys Ala Pro Pro Ala Thr Cys Ser Thr Leu Asn Pro Tyr Tyr 
20 25 30 
Ala Gln Cys Leu 
35 
<210> SEQ ID NO 22 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM, Trichoderma sp. SSL 
28 
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29 
-continued 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endoglucanase IV 
<400> SEQUENCE, 22 
Thr Gln Thr Leu Tyr Gly Gln Cys Gly Gly Ser Gly Tyr Ser Gly Pro 
1 5 10 15 
Thr Arg Cys Ala Pro Pro Ala Thr Cys Ser Thr Leu Asn Pro Tyr Tyr 
20 25 30 
Ala Gln Cys Leu 
35 
<210> SEQ ID NO 23 
<211> LENGTH, 33 
<212> TYPE, PRT 
<213> ORGANISM: Penicillium echinulatum 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endoglucanase 1 
<400> SEQUENCE, 23 
His Trp Ala Gln Cys Gly Gly Val Gly Tyr Ser Gly Pro Thr Ala Cys 
1 5 10 15 
Ala Ser Pro Tyr Thr Cys Lys Val Gln Asn Asp Tyr Tyr Ser Gln Cys 
20 25 30 
Leu 
<210> SEQ ID NO 24 
<211> LENGTH, 35 
<212> TYPE, PRT 
<213> ORGANISM: Trichoderma viride 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endoglucanase II 
<400> SEQUENCE, 24 
Gln Thr Val Trp Gly Gln Cys Gly Gly Ile Gly Trp Ser Gly Pro Thr 
1 5 10 15 
Ser Cys Ala Pro Gly Ser Ala Cys Ser Thr Leu Asn Pro Tyr Tyr Ala 
Gln Cys Ile 
35 
20 25 30 
<210> SEQ ID NO 25 
<211> LENGTH, 35 
<212> TYPE, PRT 
<213> ORGANISM: Trichoderma viride 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endoglucanase III 
<400> SEQUENCE, 25 
Gln Thr Val Trp Gly Gln Cys Gly Gly Ile Gly Trp Ser Gly Pro Thr 
1 5 10 15 
Asn Cys Ala Pro Gly Ser Ala Cys Ser Thr Leu Asn Pro Tyr Tyr Ala 
Gln Cys Ile 
35 
20 25 30 
<210> SEQ ID NO 26 
<211> LENGTH, 35 
<212> TYPE, PRT 
<213> ORGANISM: Hypocrea jecorina 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endoglucanase III 
<400> SEQUENCE, 26 
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31 
-continued 
Gln Thr Val Trp Gly Gln Cys Gly Gly Ile Gly Trp Ser Gly Pro Thr 
1 5 10 15 
Asn Cys Ala Pro Gly Ser Ala Cys Ser Thr Leu Asn Pro Tyr Tyr Ala 
Gln Cys Ile 
35 
20 25 30 
<210> SEQ ID NO 27 
<211> LENGTH, 35 
<212> TYPE, PRT 
<213> ORGANISM: Hypocrea jecorina 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endoglucanase II 
<400> SEQUENCE, 27 
Gln Thr Val Trp Gly Gln Cys Gly Gly Ile Gly Trp Ser Gly Pro Thr 
1 5 10 15 
Asn Cys Ala Pro Gly Ser Ala Cys Ser Thr Leu Asn Pro Tyr Tyr Ala 
Gln Cys Ile 
35 
20 25 30 
<210> SEQ ID NO 28 
<211> LENGTH, 35 
<212> TYPE, PRT 
<213> ORGANISM: Nectria haematococca 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from glycoside hydrolase 
family 5 
<400> SEQUENCE, 28 
Gln Val Lys Tyr Gly Gln Cys Gly Gly Ser Gly Trp Thr Gly Pro Thr 
1 5 10 15 
Leu Cys Glu Ser Gly Ser Thr Cys Gln Val Gln Asn Gln Trp Tyr Ser 
Gln Cys Leu 
35 
20 25 30 
<210> SEQ ID NO 29 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM, Glomerella graminicola Ml.001 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from glycosyl hydrolase family 
61 
<400> SEQUENCE, 29 
Thr Val Pro Lys Tyr Gly Gln Cys Gly Gly Gln Gly Trp Ser Gly Pro 
1 5 10 15 
Thr Thr Cys Ala Ser Gly Ser Thr Cys Gln Ala Leu Asn Asp Phe Tyr 
20 25 30 
Ser Gln Cys Val 
35 
<210> SEQ ID NO 30 
<211> LENGTH, 35 
<212> TYPE, PRT 
<213> ORGANISM, Irpex lacteus 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellulase 
<400> SEQUENCE, 30 
Thr Val Ala Gln Trp Gly Gln Cys Gly Gly Thr Gly Phe Thr Gly Pro 
1 5 10 15 
32 
US 8,506,717 B2 
33 
-continued 
Thr Val Cys Ala Ser Pro Phe Thr Cys His Val Val Asn Pro Tyr Tyr 
Ser Gln Cys 
35 
20 25 30 
<210> SEQ ID NO 31 
<211> LENGTH, 33 
<212> TYPE, PRT 
<213> ORGANISM: Phanerochaete chrysosporium 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endo-1,4-beta-xylanase C 
precursor 
<400> SEQUENCE, 31 
Glu Trp Gly Gln Cys Gly Gly Ile Gly Trp Thr Gly Pro Thr Thr Cys 
1 5 10 15 
Val Ala Gly Thr Thr Cys Val Glu Ser Asn Pro Tyr Tyr Ser Gln Cys 
20 25 30 
Leu 
<210> SEQ ID NO 32 
<211> LENGTH, 32 
<212> TYPE, PRT 
<213> ORGANISM: Penicillium oxalicum 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endoglucanase I 
<400> SEQUENCE, 32 
Trp Gly Gln Cys Gly Gly Gln Gly Tyr Thr Gly Pro Thr Ala Cys Val 
1 5 10 15 
Ser Gly Thr Thr Cys Lys Ala Gln Asn Pro Tyr Tyr Ser Gln Cys Leu 
20 25 30 
<210> SEQ ID NO 33 
<211> LENGTH, 32 
<212> TYPE, PRT 
<213> ORGANISM: Penicillium decumbens 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from endoglucanase I 
<400> SEQUENCE, 33 
Trp Gly Gln Cys Gly Gly Gln Gly Tyr Thr Gly Pro Thr Ala Cys Val 
1 5 10 15 
Ser Gly Thr Thr Cys Lys Ala Gln Asn Pro Tyr Tyr Ser Gln Cys Leu 
20 25 30 
<210> SEQ ID NO 34 
<211> LENGTH, 32 
<212> TYPE, PRT 
<213> ORGANISM: Talaromyces emersonii 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellulose binding protein 
<400> SEQUENCE, 34 
Trp Gly Gln Cys Gly Gly Leu Gly Trp Thr Gly Pro Thr Val Cys Ala 
1 5 10 15 
Ser Gly Phe Thr Cys Thr Val Ile Asn Glu Tyr Tyr Ser Gln Cys Leu 
20 25 30 
<210> SEQ ID NO 35 
<211> LENGTH, 32 
<212> TYPE, PRT 
<213> ORGANISM: Phanerochaete chrysosporium 
<220> FEATURE, 
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35 
-continued 
<223> OTHER INFORMATION, part of sequence from cellulose-binding 
beta-glucosidase 
<400> SEQUENCE, 35 
Tyr Gln Gln Cys Gly Gly Ile Gly Trp Thr Gly Ala Thr Thr Cys Val 
1 5 10 15 
Ser Gly Ala Thr Cys Thr Val Leu Asn Pro Tyr Tyr Ser Gln Cys Leu 
20 25 30 
<210> SEQ ID NO 36 
<211> LENGTH, 34 
<212> TYPE, PRT 
<213> ORGANISM, Aspergillus fumigatus Af293 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from Acetyl xylan esterase 
<400> SEQUENCE, 36 
Glu His Trp Gly Gln Cys Gly Gly Asn Gly Trp Thr Gly Pro Thr Ala 
1 5 10 15 
Cys Ala Ser Gly Tyr Thr Cys Thr Val Ile Asn Glu Trp Tyr Ser Gln 
20 25 30 
Cys Leu 
<210> SEQ ID NO 37 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM, Coprinopsis cinerea okayama7#130 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from glycosyl hydrolase family 
62 protein 
<400> SEQUENCE, 37 
Thr Ala Asp His Trp Ala Gln Cys Gly Gly Arg Gly Phe Ser Gly Pro 
1 5 10 15 
Thr Thr Cys Ala Ser Gly Ala Val Cys Thr Val Val Asn Glu Trp Tyr 
20 25 30 
Ser Gln Cys Ile 
35 
<210> SEQ ID NO 38 
<211> LENGTH, 34 
<212> TYPE, PRT 
<213> ORGANISM: Phanerochaete chrysosporium 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from Family 61 endoglucanase 
<400> SEQUENCE, 38 
Ala Lys Tyr Gly Gln Cys Gly Gly Leu Thr Tyr Thr Gly Pro Thr Thr 
1 5 10 15 
Cys Val Ser Gly Thr Thr Cys Thr Ala Leu Asn Asp Tyr Tyr Ser Gln 
20 25 30 
Cys Leu 
<210> SEQ ID NO 39 
<211> LENGTH, 35 
<212> TYPE, PRT 
<213> ORGANISM, Aspergillus clavatus NRRL 1 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from Fungal cellulose binding 
domain protein 
<400> SEQUENCE, 39 
Gln Ser Leu Tyr Gly Gln Cys Gly Gly Asn Gly Trp Ser Gly Pro Thr 
1 5 10 15 
36 
US 8,506,717 B2 
37 
-continued 
Glu Cys Thr Ala Gly Ala Cys Cys Gln Val Gln Asn Pro Trp Tyr Ser 
Gln Cys Leu 
35 
20 25 30 
<210> SEQ ID NO 40 
<211> LENGTH, 36 
<212> TYPE, PRT 
<213> ORGANISM, Lentinula edodes 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellulase CEL7A 
<400> SEQUENCE, 40 
Thr Gln Thr Lys Tyr Gly Gln Cys Gly Gly Gln Gly Trp Thr Gly Ala 
1 5 10 15 
Thr Val Cys Ala Ser Gly Ser Thr Cys Thr Ser Ser Gly Pro Tyr Tyr 
20 25 30 
Ser Gln Cys Leu 
35 
<210> SEQ ID NO 41 
<211> LENGTH, 34 
<212> TYPE, PRT 
<213> ORGANISM, Verticillium albo-atrum VaMs.102 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from exoglucanase 
<400> SEQUENCE, 41 
Ser Gln Trp Gly Gln Cys Gly Gly Gln Gly Trp Ser Gly Pro Thr Cys 
1 5 10 15 
Cys Pro Ser Gly Thr Thr Cys Gln Leu Gln Asn Ala Trp Tyr Ser Gln 
20 25 30 
Cys Leu 
<210> SEQ ID NO 42 
<211> LENGTH, 35 
<212> TYPE, PRT 
<213> ORGANISM, Acremonium cellulolyticus Y-94 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellobiohydrolase II 
<400> SEQUENCE, 42 
Gln Ser Val Trp Gly Gln Cys Gly Gly Gln Gly Trp Ser Gly Ala Thr 
1 5 10 15 
Ser Cys Ala Ala Gly Ser Thr Cys Ser Thr Leu Asn Pro Tyr Tyr Ala 
Gln Cys Ile 
35 
20 25 30 
<210> SEQ ID NO 43 
<211> LENGTH, 33 
<212> TYPE, PRT 
<213> ORGANISM, Neosartorya fischeri NRRL 181 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from glycosyl hydrolase family 
7 protein 
<400> SEQUENCE, 43 
His Tyr Gly Gln Cys Gly Gly Asn Gly Trp Gln Gly Pro Thr Thr Cys 
1 5 10 15 
Ala Ser Pro Tyr Thr Cys Gln Lys Leu Asn Asp Phe Tyr Ser Gln Cys 
20 25 30 
38 
US 8,506,717 B2 
39 40 
-continued 
Leu 
<210> SEQ ID NO 44 
<211> LENGTH, 32 
<212> TYPE, PRT 
<213> ORGANISM, Lentinula edodes 
<220> FEATURE, 
<223> OTHER INFORMATION, part of sequence from cellulase CEL6B 
<400> SEQUENCE, 44 
Tyr Gly Gln Cys Gly Gly Ile Gly Trp Ser Gly Ala Thr Thr Cys Val 
1 5 10 
Ser Gly Ala Thr Cys Thr Val Val Asn Ala Tyr Tyr Ser 
20 25 
What is claimed is: 
1. A pre-treatment process for treating a feedstock com-
prising holocellulose wherein the process comprises: 
a) mixing the feedstock with a solution comprising cellu-
lose binding domains to form a mixture; and 
b) subjecting the mixture to conditions sufficient to reduce 
the crystallinity ofholocellulose prior to hydrolysis. 
2. The process of claim 1 wherein the cellulose binding 
domains are derived from cellobiohydrolase I ( cel7 A) or cel-
lobiohydrolase II (cel6A). 
3. The process of claim 1 wherein the cellulose binding 
domains are derived from cellobiohydrolase I ( cel7 A) pro-
duced by Trichoderma reesei. 
4. The process of claim 1 wherein the mixture is subjected 
to a temperature of greater than about 30° C. for a time 
sufficient to reduce the crystallinity of holocellulose. 
5. The process of claim 1 wherein the mixture is subjected 
to a temperature of greater than about 35° C. for a time 
sufficient to reduce the crystallinity of holocellulose. 
15 
Gln Cys Leu 
30 
14. The process of claim 1 wherein the solution comprising 
20 cellulose binding domains further comprises a suitable buffer 
wherein the solution has a pH of from about 4.5 to about 5.5. 
15. The process of claim 1 wherein the solution comprising 
cellulose binding domains further comprises a suitable buffer 
comprising sodium acetate wherein the solution has a pH of 
25 
from about 4.5 to about 5.5. 
16. The process of claim 1 wherein the solution comprising 
cellulose binding domains further comprises a 25 to 75 mM 
sodium acetate buffer wherein the solution has a pH of about 
5. 
~ 7. The process of claim 1 which further comprises hydro-
3o !~~mg the pr?~uct of step 1 b in claim 1 to produce a compo-
s1t10n compnsmg at least one fermentable sugar. 
18. The process of claim 17 wherein the fermentable sugar 
in said composition is at least about 10% more than a com-
parable process which does not employ cellulose binding 
35 domains. 
19. The process of claim 1 wherein the ratio of cellulose 
binding domains to catalytic domain is greater than 1 : 1. 
20. The process of claim 1 wherein the ratio of cellulose 
binding domains to catalytic domain is greater than 5: 1. 
6. The process of claim 1 wherein the mixture is subjected 
to a temperature of from about 30° C. up to about 50° C. for 
a time sufficient to reduce the crystallinity ofholocellulose. 40 
7. The process of claim 1 wherein the mixture is subjected 
21. A pre-treatment composition suitable for reducing the 
crystallinity of cellulose prior to hydrolysis, said composition 
comprising cellulose, a suitable concentration of a solution 
comprising cellulose binding domains, and a suitable buffer 
selected from the group consisting of lower alkyl acid salts 
and lower alkyl acid esters. 
to a temperature of from about 35° C. up to about 45° C. for 
a time sufficient to reduce the crystallinity ofholocellulose. 
8. The process of claim 1 wherein the mixture is subjected 
to increased temperature for at least about 8 hours. 45 
9. The process of claim 1 wherein the mixture is subjected 
to increased temperature for at least about 10 hours. 
10. The process of claim 1 wherein the mixture is subjected 
to increased temperature for at least about 12 hours. 
11. The process of claim 1 wherein the mixture is subjected 50 
to stirring such that substantially all solids are suspended. 
12. The process of claim 1 wherein the solution comprising 
cellulose binding domains has a concentration of from about 
5 to about 55 µg/ml. 
13. The process of claim 1 wherein the solution comprising 55 
cellulose binding domains further comprises a suitable buffer 
selected from the group consisting of lower alkyl acid salts 
and lower alkyl acid esters. 
22. The composition of claim 21 wherein the cellulose 
binding domains are derived from cellobiohydrolase I 
(cel7A) produced by Trichoderma reesei. 
23. The composition of claim 21 wherein the solution 
comprising cellulose binding domains has a concentration of 
from about 5 to about 55 µg/ml wherein the buffer comprises 
a 25 to 7 5 mM sodium acetate buffer and wherein the solution 
has a pH of about 5. 
24. The composition of claim 21 wherein the solution 
comprising cellulose binding domains has a ratio of cellulose 
binding domains to catalytic domain which is greater than 
5:1. 
* * * * * 
